BRCA1 and cancer: This is especially true when it comes to assignment of flat signatures: our original analysis demonstrates that the previously identified presence of BRCA1/BRCA2-like HRD in an MM cohort is likely to be a false-positive call of fitting algorithms32, but this can only be demonstrated knowing the actual genomic consequences of BRCA deficiency in cancers and comparing them to what is seen in MM.